Study: Human blood antibody relieves chronic pain condition

02/1/2010 | National Post (Canada)

U.K. scientists found that almost half of 13 patients with complex regional pain syndrome experienced pain relief for an average of five weeks after receiving a low-dose transfusion of intravenous immunoglobulin, a human blood antibody. "The discovery is expected to have a real impact on the treatment of other unexplained chronic pain conditions," the lead researcher said.

View Full Article in:

National Post (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA